Get started
Roche Holding LtdRoche Holding LtdRoche Holding Ltd

Roche Holding Ltd

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪305.16 B‬ EUR
Dividend yield (indicated)
2.70%
Price to earnings Ratio (TTM)
30.6
Basic EPS (TTM)
12.6 EUR
Net income (FY)
‪8.80 B‬ EUR
Revenue (FY)
‪64.34 B‬ EUR
Shares float
‪29.01 M‬
Beta (1Y)
1.49

Employees


Employees (FY)
‪103.25 K‬
Change (1Y)
−356 −0.34%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Roche Holding Ltd


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Schinecker
Website
roche.com
Headquarters
Basel
Founded
1896
Identifiers
2
ISIN CH0012032113
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as RHO.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051
Yield to maturity
5.42%
Maturity date
Dec 13, 2051
R
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.34%
Maturity date
Mar 8, 2054
R
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.33%
Maturity date
Mar 8, 2054
G
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035
Yield to maturity
5.30%
Maturity date
Jul 15, 2035
R
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044
Yield to maturity
5.19%
Maturity date
Nov 28, 2044
R
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
5.15%
Maturity date
Mar 8, 2034
R
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031
Yield to maturity
5.07%
Maturity date
Mar 8, 2031
R
CHGCY5766479
Roche Holdings, Inc. 4.79% 08-MAR-2029
Yield to maturity
4.95%
Maturity date
Mar 8, 2029
R
CHGCY4391962
Roche Holdings, Inc. 7.0% 01-MAR-2039
Yield to maturity
4.95%
Maturity date
Mar 1, 2039
R
CHGCY6244754
Roche Holdings, Inc. 4.666% 02-DEC-2035
Yield to maturity
4.73%
Maturity date
Dec 2, 2035
R
CHGCY5766484
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
4.64%
Maturity date
Mar 8, 2034

See all RHO bonds 

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight
0.03%
Market value
‪178.85 M‬
USD
VEA
Vanguard FTSE Developed Markets ETF
Weight
0.04%
Market value
‪121.15 M‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
0.05%
Market value
‪95.21 M‬
USD
SMMCHA
UBS ETF (CH) - UBS SMIM(R) ETF Anteile -CHF dis-
Weight
3.90%
Market value
‪84.60 M‬
USD
CSSMIM
iShares SMIM(R) ETF (CH)
Weight
3.87%
Market value
‪58.61 M‬
USD
ESGD
iShares ESG Aware MSCI EAFE ETF
Weight
0.46%
Market value
‪52.59 M‬
USD
EFA
iShares MSCI EAFE ETF
Weight
0.07%
Market value
‪49.48 M‬
USD
CHSPI
iShares Core SPI(R) ETF (CH)
Weight
0.60%
Market value
‪40.37 M‬
USD
VGK
Vanguard FTSE Europe ETF
Weight
0.09%
Market value
‪32.26 M‬
USD
VT
Vanguard Total World Stock ETF
Weight
0.04%
Market value
‪30.48 M‬
USD
SW2CHA
UBS ETF SICAV - UBS ETF - MSCI Switzerland 20/35 UCITS ETF A Distribution
Weight
0.73%
Market value
‪29.50 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of RHO is 384.6 EUR — it has decreased by −3.73% in the past 24 hours. Watch Roche Holding Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange Roche Holding Ltd stocks are traded under the ticker RHO.
RHO stock has fallen by −0.11% compared to the previous week, the month change is a 3.92% rise, over the last year Roche Holding Ltd has showed a 56.72% increase.
We've gathered analysts' opinions on Roche Holding Ltd future price: according to them, RHO price has a max estimate of 465.84 EUR and a min estimate of 250.92 EUR. Watch RHO chart and read a more detailed Roche Holding Ltd stock forecast: see what analysts think of Roche Holding Ltd and suggest that you do with its stocks.
RHO reached its all-time high on Jan 23, 2026 with the price of 384.8 EUR, and its all-time low was 87.0 EUR and was reached on Mar 12, 2003. View more price dynamics on RHO chart.
See other stocks reaching their highest and lowest prices.
RHO stock is 3.44% volatile and has beta coefficient of 1.49. Track Roche Holding Ltd stock price on the chart and check out the list of the most volatile stocks — is Roche Holding Ltd there?
Today Roche Holding Ltd has the market capitalization of ‪300.47 B‬, it has decreased by −1.73% over the last week.
Yes, you can track Roche Holding Ltd financials in yearly and quarterly reports right on TradingView.
Roche Holding Ltd is going to release the next earnings report on Jul 23, 2026. Keep track of upcoming events with our Earnings Calendar.
RHO earnings for the last half-year are 9.00 EUR per share, whereas the estimation was 9.22 EUR, resulting in a −2.38% surprise. The estimated earnings for the next half-year are 11.92 EUR per share. See more details about Roche Holding Ltd earnings.
Roche Holding Ltd revenue for the last half-year amounts to ‪33.58 B‬ EUR, despite the estimated figure of ‪33.39 B‬ EUR. In the next half-year revenue is expected to reach ‪33.60 B‬ EUR.
RHO net income for the last half-year is ‪6.41 B‬ EUR, while the previous report showed ‪7.93 B‬ EUR of net income which accounts for −19.17% change. Track more Roche Holding Ltd financial stats to get the full picture.
Yes, RHO dividends are paid annually. The last dividend per share was 10.17 EUR. As of today, Dividend Yield (TTM)% is 2.80%. Tracking Roche Holding Ltd dividends might help you take more informed decisions.
As of Jan 29, 2026, the company has ‪103.25 K‬ employees. See our rating of the largest employees — is Roche Holding Ltd on this list?
Like other stocks, RHO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Roche Holding Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Roche Holding Ltd technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Roche Holding Ltd stock shows the strong buy signal. See more of Roche Holding Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.